V-set domain-containing T-cell activation inhibitor 1

[1]. Ilona Kryczek, et al. Relationship between B7-H4, regulatory T cells, and patient outcome in human ovarian carcinoma. Cancer Res. 2007 Sep 15;67(18):8900-5. [Content Brief]

[2]. Ilona Kryczek, et al. B7-H4 expression identifies a novel suppressive macrophage population in human ovarian carcinoma. J Exp Med. 2006 Apr 17;203(4):871-81. [Content Brief]

[3]. Susana Salceda, et al. The immunomodulatory protein B7-H4 is overexpressed in breast and ovarian cancers and promotes epithelial cell transformation. Exp Cell Res. 2005 May 15;306(1):128-41. [Content Brief]

[4]. Takashi Miyatake, et al. B7-H4 (DD-O110) is overexpressed in high risk uterine endometrioid adenocarcinomas and inversely correlated with tumor T-cell infiltration. Gynecol Oncol. 2007 Jul;106(1):119-27. [Content Brief]